| 1 | 1 | | I |
|---|
| 2 | 2 | | 118THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 171 |
|---|
| 5 | 5 | | To amend the Controlled Substances Act with respect to the scheduling |
|---|
| 6 | 6 | | of fentanyl-related substances, and for other purposes. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | JANUARY9, 2023 |
|---|
| 9 | 9 | | Mr. G |
|---|
| 10 | 10 | | RIFFITH(for himself and Mr. LATTA) introduced the following bill; |
|---|
| 11 | 11 | | which was referred to the Committee on Energy and Commerce, and in |
|---|
| 12 | 12 | | addition to the Committee on the Judiciary, for a period to be subse- |
|---|
| 13 | 13 | | quently determined by the Speaker, in each case for consideration of such |
|---|
| 14 | 14 | | provisions as fall within the jurisdiction of the committee concerned |
|---|
| 15 | 15 | | A BILL |
|---|
| 16 | 16 | | To amend the Controlled Substances Act with respect to |
|---|
| 17 | 17 | | the scheduling of fentanyl-related substances, and for |
|---|
| 18 | 18 | | other purposes. |
|---|
| 19 | 19 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 20 | 20 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 21 | 21 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 22 | 22 | | This Act may be cited as the ‘‘Halt All Lethal Traf-4 |
|---|
| 23 | 23 | | ficking of Fentanyl Act’’ or the ‘‘HALT Fentanyl Act’’. 5 |
|---|
| 24 | 24 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 25 | 25 | | pbinns on DSKJLVW7X2PROD with $$_JOB 2 |
|---|
| 26 | 26 | | •HR 171 IH |
|---|
| 27 | 27 | | SEC. 2. CLASS SCHEDULING OF FENTANYL-RELATED SUB-1 |
|---|
| 28 | 28 | | STANCES. 2 |
|---|
| 29 | 29 | | Section 202(c) of the Controlled Substances Act (21 3 |
|---|
| 30 | 30 | | U.S.C. 812(c)) is amended by adding at the end of sched-4 |
|---|
| 31 | 31 | | ule I the following: 5 |
|---|
| 32 | 32 | | ‘‘(e)(1) Unless specifically exempted or unless listed 6 |
|---|
| 33 | 33 | | in another schedule, any material, compound, mixture, or 7 |
|---|
| 34 | 34 | | preparation which contains any quantity of a fentanyl-re-8 |
|---|
| 35 | 35 | | lated substance, or which contains the salts, isomers, and 9 |
|---|
| 36 | 36 | | salts of isomers of a fentanyl-related substance whenever 10 |
|---|
| 37 | 37 | | the existence of such salts, isomers, and salts of isomers 11 |
|---|
| 38 | 38 | | is possible within the specific chemical designation. 12 |
|---|
| 39 | 39 | | ‘‘(2) For purposes of paragraph (1), except as pro-13 |
|---|
| 40 | 40 | | vided in paragraph (3), the term ‘fentanyl-related sub-14 |
|---|
| 41 | 41 | | stance’ means any substance that is structurally related 15 |
|---|
| 42 | 42 | | to fentanyl by 1 or more of the following modifications: 16 |
|---|
| 43 | 43 | | ‘‘(A) By replacement of the phenyl portion of 17 |
|---|
| 44 | 44 | | the phenethyl group by any monocycle, whether or 18 |
|---|
| 45 | 45 | | not further substituted in or on the monocycle. 19 |
|---|
| 46 | 46 | | ‘‘(B) By substitution in or on the phenethyl 20 |
|---|
| 47 | 47 | | group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, 21 |
|---|
| 48 | 48 | | haloalkyl, amino, or nitro groups. 22 |
|---|
| 49 | 49 | | ‘‘(C) By substitution in or on the piperidine 23 |
|---|
| 50 | 50 | | ring with alkyl, alkenyl, alkoxyl, ester, ether, 24 |
|---|
| 51 | 51 | | hydroxyl, halo, haloalkyl, amino, or nitro groups. 25 |
|---|
| 52 | 52 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 53 | 53 | | pbinns on DSKJLVW7X2PROD with $$_JOB 3 |
|---|
| 54 | 54 | | •HR 171 IH |
|---|
| 55 | 55 | | ‘‘(D) By replacement of the aniline ring with 1 |
|---|
| 56 | 56 | | any aromatic monocycle whether or not further sub-2 |
|---|
| 57 | 57 | | stituted in or on the aromatic monocycle. 3 |
|---|
| 58 | 58 | | ‘‘(E) By replacement of the N–propionyl group 4 |
|---|
| 59 | 59 | | with another acyl group. 5 |
|---|
| 60 | 60 | | ‘‘(3) A substance that satisfies the definition of the 6 |
|---|
| 61 | 61 | | term ‘fentanyl-related substance’ in paragraph (2) shall 7 |
|---|
| 62 | 62 | | nonetheless not be treated as a fentanyl-related substance 8 |
|---|
| 63 | 63 | | subject to this schedule if the substance— 9 |
|---|
| 64 | 64 | | ‘‘(A) is controlled by action of the Attorney 10 |
|---|
| 65 | 65 | | General under section 201; or 11 |
|---|
| 66 | 66 | | ‘‘(B) is otherwise expressly listed in a schedule 12 |
|---|
| 67 | 67 | | other than this schedule. 13 |
|---|
| 68 | 68 | | ‘‘(4)(A) The Attorney General may by order publish 14 |
|---|
| 69 | 69 | | in the Federal Register a list of substances that satisfy 15 |
|---|
| 70 | 70 | | the definition of the term ‘fentanyl-related substance’ in 16 |
|---|
| 71 | 71 | | paragraph (2). 17 |
|---|
| 72 | 72 | | ‘‘(B) The absence of a substance from a list published 18 |
|---|
| 73 | 73 | | under subparagraph (A) does not negate the control status 19 |
|---|
| 74 | 74 | | of the substance under this schedule if the substance satis-20 |
|---|
| 75 | 75 | | fies the definition of the term ‘fentanyl-related substance’ 21 |
|---|
| 76 | 76 | | in paragraph (2).’’. 22 |
|---|
| 77 | 77 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 78 | 78 | | pbinns on DSKJLVW7X2PROD with $$_JOB 4 |
|---|
| 79 | 79 | | •HR 171 IH |
|---|
| 80 | 80 | | SEC. 3. REGISTRATION REQUIREMENTS RELATED TO RE-1 |
|---|
| 81 | 81 | | SEARCH. 2 |
|---|
| 82 | 82 | | (a) A |
|---|
| 83 | 83 | | LTERNATIVE REGISTRATIONPROCESS FOR 3 |
|---|
| 84 | 84 | | S |
|---|
| 85 | 85 | | CHEDULEI RESEARCH.—Section 303 of the Controlled 4 |
|---|
| 86 | 86 | | Substances Act (21 U.S.C. 823) is amended by adding at 5 |
|---|
| 87 | 87 | | the end the following: 6 |
|---|
| 88 | 88 | | ‘‘(m) S |
|---|
| 89 | 89 | | PECIALPROVISIONS FOR PRACTITIONERS 7 |
|---|
| 90 | 90 | | C |
|---|
| 91 | 91 | | ONDUCTINGCERTAINRESEARCHWITHSCHEDULEI 8 |
|---|
| 92 | 92 | | C |
|---|
| 93 | 93 | | ONTROLLEDSUBSTANCES.— 9 |
|---|
| 94 | 94 | | ‘‘(1) I |
|---|
| 95 | 95 | | N GENERAL.—Notwithstanding subsection 10 |
|---|
| 96 | 96 | | (f), a practitioner may conduct research described in 11 |
|---|
| 97 | 97 | | paragraph (2) of this subsection with 1 or more 12 |
|---|
| 98 | 98 | | schedule I substances in accordance with subpara-13 |
|---|
| 99 | 99 | | graph (A) or (B) of paragraph (3) of this sub-14 |
|---|
| 100 | 100 | | section. 15 |
|---|
| 101 | 101 | | ‘‘(2) R |
|---|
| 102 | 102 | | ESEARCH SUBJECT TO EXPEDITED PRO -16 |
|---|
| 103 | 103 | | CEDURES.—Research described in this paragraph is 17 |
|---|
| 104 | 104 | | research that— 18 |
|---|
| 105 | 105 | | ‘‘(A) is with respect to a drug that is the 19 |
|---|
| 106 | 106 | | subject of an investigational use exemption 20 |
|---|
| 107 | 107 | | under section 505(i) of the Federal Food, Drug, 21 |
|---|
| 108 | 108 | | and Cosmetic Act; or 22 |
|---|
| 109 | 109 | | ‘‘(B) is— 23 |
|---|
| 110 | 110 | | ‘‘(i) conducted by the Department of 24 |
|---|
| 111 | 111 | | Health and Human Services or the De-25 |
|---|
| 112 | 112 | | partment of Veterans Affairs; or 26 |
|---|
| 113 | 113 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 114 | 114 | | pbinns on DSKJLVW7X2PROD with $$_JOB 5 |
|---|
| 115 | 115 | | •HR 171 IH |
|---|
| 116 | 116 | | ‘‘(ii) funded partly or entirely by a 1 |
|---|
| 117 | 117 | | grant, contract, cooperative agreement, or 2 |
|---|
| 118 | 118 | | other transaction from the Department of 3 |
|---|
| 119 | 119 | | Health and Human Services or the De-4 |
|---|
| 120 | 120 | | partment of Veterans Affairs. 5 |
|---|
| 121 | 121 | | ‘‘(3) E |
|---|
| 122 | 122 | | XPEDITED PROCEDURES .— 6 |
|---|
| 123 | 123 | | ‘‘(A) R |
|---|
| 124 | 124 | | ESEARCHER WITH A CURRENT 7 |
|---|
| 125 | 125 | | SCHEDULE I OR II RESEARCH REGISTRATION .— 8 |
|---|
| 126 | 126 | | ‘‘(i) I |
|---|
| 127 | 127 | | N GENERAL.—If a practitioner is 9 |
|---|
| 128 | 128 | | registered to conduct research with a con-10 |
|---|
| 129 | 129 | | trolled substance in schedule I or II, the 11 |
|---|
| 130 | 130 | | practitioner may conduct research under 12 |
|---|
| 131 | 131 | | this subsection on and after the date that 13 |
|---|
| 132 | 132 | | is 30 days after the date on which the 14 |
|---|
| 133 | 133 | | practitioner sends a notice to the Attorney 15 |
|---|
| 134 | 134 | | General containing the following informa-16 |
|---|
| 135 | 135 | | tion, with respect to each substance with 17 |
|---|
| 136 | 136 | | which the practitioner will conduct the re-18 |
|---|
| 137 | 137 | | search: 19 |
|---|
| 138 | 138 | | ‘‘(I) The chemical name of the 20 |
|---|
| 139 | 139 | | substance. 21 |
|---|
| 140 | 140 | | ‘‘(II) The quantity of the sub-22 |
|---|
| 141 | 141 | | stance to be used in the research. 23 |
|---|
| 142 | 142 | | ‘‘(III) Demonstration that the re-24 |
|---|
| 143 | 143 | | search is in the category described in 25 |
|---|
| 144 | 144 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 145 | 145 | | pbinns on DSKJLVW7X2PROD with $$_JOB 6 |
|---|
| 146 | 146 | | •HR 171 IH |
|---|
| 147 | 147 | | paragraph (2), which demonstration 1 |
|---|
| 148 | 148 | | may be satisfied— 2 |
|---|
| 149 | 149 | | ‘‘(aa) in the case of a grant, 3 |
|---|
| 150 | 150 | | contract, cooperative agreement, 4 |
|---|
| 151 | 151 | | or other transaction, or intra-5 |
|---|
| 152 | 152 | | mural research project, by identi-6 |
|---|
| 153 | 153 | | fying the sponsoring agency and 7 |
|---|
| 154 | 154 | | supplying the number of the 8 |
|---|
| 155 | 155 | | grant, contract, cooperative 9 |
|---|
| 156 | 156 | | agreement, other transaction, or 10 |
|---|
| 157 | 157 | | project; or 11 |
|---|
| 158 | 158 | | ‘‘(bb) in the case of an ap-12 |
|---|
| 159 | 159 | | plication under section 505(i) of 13 |
|---|
| 160 | 160 | | the Federal Food, Drug, and 14 |
|---|
| 161 | 161 | | Cosmetic Act, by supplying the 15 |
|---|
| 162 | 162 | | application number and the spon-16 |
|---|
| 163 | 163 | | sor of record on the application. 17 |
|---|
| 164 | 164 | | ‘‘(IV) Demonstration that the re-18 |
|---|
| 165 | 165 | | searcher is authorized to conduct re-19 |
|---|
| 166 | 166 | | search with respect to the substance 20 |
|---|
| 167 | 167 | | under the laws of the State in which 21 |
|---|
| 168 | 168 | | the research will take place. 22 |
|---|
| 169 | 169 | | ‘‘(ii) V |
|---|
| 170 | 170 | | ERIFICATION OF INFORMATION 23 |
|---|
| 171 | 171 | | BY HHS OR VA.—Upon request from the 24 |
|---|
| 172 | 172 | | Attorney General, the Secretary of Health 25 |
|---|
| 173 | 173 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 174 | 174 | | pbinns on DSKJLVW7X2PROD with $$_JOB 7 |
|---|
| 175 | 175 | | •HR 171 IH |
|---|
| 176 | 176 | | and Human Services or the Secretary of 1 |
|---|
| 177 | 177 | | Veterans Affairs, as appropriate, shall 2 |
|---|
| 178 | 178 | | verify information submitted by an appli-3 |
|---|
| 179 | 179 | | cant under clause (i)(III). 4 |
|---|
| 180 | 180 | | ‘‘(B) R |
|---|
| 181 | 181 | | ESEARCHER WITHOUT A CURRENT 5 |
|---|
| 182 | 182 | | SCHEDULE I OR II RESEARCH REGISTRATION .— 6 |
|---|
| 183 | 183 | | ‘‘(i) I |
|---|
| 184 | 184 | | N GENERAL.—If a practitioner is 7 |
|---|
| 185 | 185 | | not registered to conduct research with a 8 |
|---|
| 186 | 186 | | controlled substance in schedule I or II, 9 |
|---|
| 187 | 187 | | the practitioner may send a notice to the 10 |
|---|
| 188 | 188 | | Attorney General containing the informa-11 |
|---|
| 189 | 189 | | tion listed in subparagraph (A)(i), with re-12 |
|---|
| 190 | 190 | | spect to each substance with which the 13 |
|---|
| 191 | 191 | | practitioner will conduct the research. 14 |
|---|
| 192 | 192 | | ‘‘(ii) A |
|---|
| 193 | 193 | | TTORNEY GENERAL ACTION .— 15 |
|---|
| 194 | 194 | | The Attorney General shall— 16 |
|---|
| 195 | 195 | | ‘‘(I) treat notice received under 17 |
|---|
| 196 | 196 | | clause (i) as a sufficient application 18 |
|---|
| 197 | 197 | | for a research registration; and 19 |
|---|
| 198 | 198 | | ‘‘(II) not later than 45 days of 20 |
|---|
| 199 | 199 | | receiving such a notice that contains 21 |
|---|
| 200 | 200 | | all information required under sub-22 |
|---|
| 201 | 201 | | paragraph (A)(i)— 23 |
|---|
| 202 | 202 | | ‘‘(aa) register the applicant; 24 |
|---|
| 203 | 203 | | or 25 |
|---|
| 204 | 204 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 205 | 205 | | pbinns on DSKJLVW7X2PROD with $$_JOB 8 |
|---|
| 206 | 206 | | •HR 171 IH |
|---|
| 207 | 207 | | ‘‘(bb) serve an order to show 1 |
|---|
| 208 | 208 | | cause upon the applicant in ac-2 |
|---|
| 209 | 209 | | cordance with section 304(c). 3 |
|---|
| 210 | 210 | | ‘‘(4) E |
|---|
| 211 | 211 | | LECTRONIC SUBMISSIONS .—The Attorney 4 |
|---|
| 212 | 212 | | General shall provide a means to permit a practi-5 |
|---|
| 213 | 213 | | tioner to submit a notification under paragraph (3) 6 |
|---|
| 214 | 214 | | electronically. 7 |
|---|
| 215 | 215 | | ‘‘(5) L |
|---|
| 216 | 216 | | IMITATION ON AMOUNTS .—A practitioner 8 |
|---|
| 217 | 217 | | conducting research with a schedule I substance 9 |
|---|
| 218 | 218 | | under this subsection may only possess the amounts 10 |
|---|
| 219 | 219 | | of schedule I substance identified in— 11 |
|---|
| 220 | 220 | | ‘‘(A) the notification to the Attorney Gen-12 |
|---|
| 221 | 221 | | eral under paragraph (3); or 13 |
|---|
| 222 | 222 | | ‘‘(B) a supplemental notification that the 14 |
|---|
| 223 | 223 | | practitioner may send if the practitioner needs 15 |
|---|
| 224 | 224 | | additional amounts for the research, which sup-16 |
|---|
| 225 | 225 | | plemental notification shall include— 17 |
|---|
| 226 | 226 | | ‘‘(i) the name of the practitioner; 18 |
|---|
| 227 | 227 | | ‘‘(ii) the additional quantity needed of 19 |
|---|
| 228 | 228 | | the substance; and 20 |
|---|
| 229 | 229 | | ‘‘(iii) an attestation that the research 21 |
|---|
| 230 | 230 | | to be conducted with the substance is con-22 |
|---|
| 231 | 231 | | sistent with the scope of the research that 23 |
|---|
| 232 | 232 | | was the subject of the notification under 24 |
|---|
| 233 | 233 | | paragraph (3). 25 |
|---|
| 234 | 234 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 235 | 235 | | pbinns on DSKJLVW7X2PROD with $$_JOB 9 |
|---|
| 236 | 236 | | •HR 171 IH |
|---|
| 237 | 237 | | ‘‘(6) IMPORTATION AND EXPORTATION RE -1 |
|---|
| 238 | 238 | | QUIREMENTS NOT AFFECTED .—Nothing in this sub-2 |
|---|
| 239 | 239 | | section alters the requirements of part A of title III, 3 |
|---|
| 240 | 240 | | regarding the importation and exportation of con-4 |
|---|
| 241 | 241 | | trolled substances.’’. 5 |
|---|
| 242 | 242 | | (b) S |
|---|
| 243 | 243 | | EPARATEREGISTRATIONSNOTREQUIRED FOR 6 |
|---|
| 244 | 244 | | A |
|---|
| 245 | 245 | | DDITIONALRESEARCHER INSAMEINSTITUTION.—Sec-7 |
|---|
| 246 | 246 | | tion 302(c) of the Controlled Substances Act (21 U.S.C. 8 |
|---|
| 247 | 247 | | 822(c)) is amended by adding at the end the following: 9 |
|---|
| 248 | 248 | | ‘‘(4) An agent or employee of a research insti-10 |
|---|
| 249 | 249 | | tution that is conducting research with a controlled 11 |
|---|
| 250 | 250 | | substance if— 12 |
|---|
| 251 | 251 | | ‘‘(A) the agent or employee is acting with-13 |
|---|
| 252 | 252 | | in the scope of the professional practice of the 14 |
|---|
| 253 | 253 | | agent or employee; 15 |
|---|
| 254 | 254 | | ‘‘(B) another agent or employee of the in-16 |
|---|
| 255 | 255 | | stitution is registered to conduct research with 17 |
|---|
| 256 | 256 | | a controlled substance in the same schedule; 18 |
|---|
| 257 | 257 | | ‘‘(C) the researcher who is so registered— 19 |
|---|
| 258 | 258 | | ‘‘(i) informs the Attorney General of 20 |
|---|
| 259 | 259 | | the name, position title, and employing in-21 |
|---|
| 260 | 260 | | stitution of the agent or employee who is 22 |
|---|
| 261 | 261 | | not separately registered; 23 |
|---|
| 262 | 262 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 263 | 263 | | pbinns on DSKJLVW7X2PROD with $$_JOB 10 |
|---|
| 264 | 264 | | •HR 171 IH |
|---|
| 265 | 265 | | ‘‘(ii) authorizes that agent or em-1 |
|---|
| 266 | 266 | | ployee to perform research under the reg-2 |
|---|
| 267 | 267 | | istration of the registered researcher; and 3 |
|---|
| 268 | 268 | | ‘‘(iii) affirms that any act taken by 4 |
|---|
| 269 | 269 | | that agent or employee involving a con-5 |
|---|
| 270 | 270 | | trolled substance shall be attributable to 6 |
|---|
| 271 | 271 | | the registered researcher, as if the re-7 |
|---|
| 272 | 272 | | searcher had directly committed the act, 8 |
|---|
| 273 | 273 | | for purposes of any proceeding under sec-9 |
|---|
| 274 | 274 | | tion 304(a) to suspend or revoke the reg-10 |
|---|
| 275 | 275 | | istration of the registered researcher; and 11 |
|---|
| 276 | 276 | | ‘‘(D) the Attorney General does not, within 12 |
|---|
| 277 | 277 | | 30 days of receiving the information, authoriza-13 |
|---|
| 278 | 278 | | tion, and affirmation described in subparagraph 14 |
|---|
| 279 | 279 | | (C), refuse, for a reason listed in section 15 |
|---|
| 280 | 280 | | 304(a), to allow the agent or employee to pos-16 |
|---|
| 281 | 281 | | sess the substance without a separate registra-17 |
|---|
| 282 | 282 | | tion.’’. 18 |
|---|
| 283 | 283 | | (c) S |
|---|
| 284 | 284 | | INGLEREGISTRATION FORRELATEDRESEARCH 19 |
|---|
| 285 | 285 | | S |
|---|
| 286 | 286 | | ITES.—Section 302(e) of the Controlled Substances Act 20 |
|---|
| 287 | 287 | | (21 U.S.C. 822(e)) is amended by adding at the end the 21 |
|---|
| 288 | 288 | | following: 22 |
|---|
| 289 | 289 | | ‘‘(3)(A) Notwithstanding paragraph (1), a person 23 |
|---|
| 290 | 290 | | registered to conduct research with a controlled substance 24 |
|---|
| 291 | 291 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00010 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 292 | 292 | | pbinns on DSKJLVW7X2PROD with $$_JOB 11 |
|---|
| 293 | 293 | | •HR 171 IH |
|---|
| 294 | 294 | | under section 303(f) may conduct the research under a 1 |
|---|
| 295 | 295 | | single registration if— 2 |
|---|
| 296 | 296 | | ‘‘(i) the research occurs exclusively on sites all 3 |
|---|
| 297 | 297 | | of which are— 4 |
|---|
| 298 | 298 | | ‘‘(I) within the same city or county; and 5 |
|---|
| 299 | 299 | | ‘‘(II) under the control of the same institu-6 |
|---|
| 300 | 300 | | tion, organization, or agency; and 7 |
|---|
| 301 | 301 | | ‘‘(ii) before commencing the research, the re-8 |
|---|
| 302 | 302 | | searcher notifies the Attorney General of each site 9 |
|---|
| 303 | 303 | | where— 10 |
|---|
| 304 | 304 | | ‘‘(I) the research will be conducted; or 11 |
|---|
| 305 | 305 | | ‘‘(II) the controlled substance will be 12 |
|---|
| 306 | 306 | | stored or administered. 13 |
|---|
| 307 | 307 | | ‘‘(B) A site described in subparagraph (A) shall be 14 |
|---|
| 308 | 308 | | included in a registration described in that subparagraph 15 |
|---|
| 309 | 309 | | only if the researcher has notified the Attorney General 16 |
|---|
| 310 | 310 | | of the site— 17 |
|---|
| 311 | 311 | | ‘‘(i) in the application for the registration; or 18 |
|---|
| 312 | 312 | | ‘‘(ii) before the research is conducted, or before 19 |
|---|
| 313 | 313 | | the controlled substance is stored or administered, at 20 |
|---|
| 314 | 314 | | the site. 21 |
|---|
| 315 | 315 | | ‘‘(C) The Attorney General may, in consultation with 22 |
|---|
| 316 | 316 | | the Secretary, issue regulations addressing, with respect 23 |
|---|
| 317 | 317 | | to research sites described in subparagraph (A)— 24 |
|---|
| 318 | 318 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 319 | 319 | | pbinns on DSKJLVW7X2PROD with $$_JOB 12 |
|---|
| 320 | 320 | | •HR 171 IH |
|---|
| 321 | 321 | | ‘‘(i) the manner in which controlled substances 1 |
|---|
| 322 | 322 | | may be delivered to the research sites; 2 |
|---|
| 323 | 323 | | ‘‘(ii) the storage and security of controlled sub-3 |
|---|
| 324 | 324 | | stances at the research sites; 4 |
|---|
| 325 | 325 | | ‘‘(iii) the maintenance of records for the re-5 |
|---|
| 326 | 326 | | search sites; and 6 |
|---|
| 327 | 327 | | ‘‘(iv) any other matters necessary to ensure ef-7 |
|---|
| 328 | 328 | | fective controls against diversion at the research 8 |
|---|
| 329 | 329 | | sites.’’. 9 |
|---|
| 330 | 330 | | (d) N |
|---|
| 331 | 331 | | EWINSPECTIONNOTREQUIRED INCERTAIN 10 |
|---|
| 332 | 332 | | S |
|---|
| 333 | 333 | | ITUATIONS.—Section 302(f) of the Controlled Sub-11 |
|---|
| 334 | 334 | | stances Act (21 U.S.C. 822(f)) is amended— 12 |
|---|
| 335 | 335 | | (1) by striking ‘‘(f) The’’ and inserting ‘‘(f)(1) 13 |
|---|
| 336 | 336 | | The’’; and 14 |
|---|
| 337 | 337 | | (2) by adding at the end the following: 15 |
|---|
| 338 | 338 | | ‘‘(2)(A) If a person is registered to conduct research 16 |
|---|
| 339 | 339 | | with a controlled substance and applies for a registration, 17 |
|---|
| 340 | 340 | | or for a modification of a registration, to conduct research 18 |
|---|
| 341 | 341 | | with a second controlled substance that is in the same 19 |
|---|
| 342 | 342 | | schedule as the first controlled substance, or is in a sched-20 |
|---|
| 343 | 343 | | ule with a higher numerical designation than the schedule 21 |
|---|
| 344 | 344 | | of the first controlled substance, a new inspection by the 22 |
|---|
| 345 | 345 | | Attorney General of the registered location is not required. 23 |
|---|
| 346 | 346 | | ‘‘(B) Nothing in subparagraph (A) shall prohibit the 24 |
|---|
| 347 | 347 | | Attorney General from conducting an inspection that the 25 |
|---|
| 348 | 348 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00012 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 349 | 349 | | pbinns on DSKJLVW7X2PROD with $$_JOB 13 |
|---|
| 350 | 350 | | •HR 171 IH |
|---|
| 351 | 351 | | Attorney General determines necessary to ensure that a 1 |
|---|
| 352 | 352 | | registrant maintains effective controls against diversion.’’. 2 |
|---|
| 353 | 353 | | (e) C |
|---|
| 354 | 354 | | ONTINUATION OF RESEARCH ONSUBSTANCES 3 |
|---|
| 355 | 355 | | N |
|---|
| 356 | 356 | | EWLYADDED TOSCHEDULEI.—Section 302 of the 4 |
|---|
| 357 | 357 | | Controlled Substances Act (21 U.S.C. 822) is amended 5 |
|---|
| 358 | 358 | | by adding at the end the following: 6 |
|---|
| 359 | 359 | | ‘‘(h) C |
|---|
| 360 | 360 | | ONTINUATION OFRESEARCH ONSUBSTANCES 7 |
|---|
| 361 | 361 | | N |
|---|
| 362 | 362 | | EWLYADDED TOSCHEDULEI.—If a person is con-8 |
|---|
| 363 | 363 | | ducting research on a substance when the substance is 9 |
|---|
| 364 | 364 | | added to schedule I, and the person is already registered 10 |
|---|
| 365 | 365 | | to conduct research with a controlled substance in sched-11 |
|---|
| 366 | 366 | | ule I— 12 |
|---|
| 367 | 367 | | ‘‘(1) not later than 90 days after the scheduling 13 |
|---|
| 368 | 368 | | of the newly scheduled substance, the person shall 14 |
|---|
| 369 | 369 | | submit a completed application for registration or 15 |
|---|
| 370 | 370 | | modification of existing registration, to conduct re-16 |
|---|
| 371 | 371 | | search on the substance, in accordance with regula-17 |
|---|
| 372 | 372 | | tions issued by the Attorney General for purposes of 18 |
|---|
| 373 | 373 | | this paragraph; 19 |
|---|
| 374 | 374 | | ‘‘(2) the person may, notwithstanding sub-20 |
|---|
| 375 | 375 | | sections (a) and (b), continue to conduct the re-21 |
|---|
| 376 | 376 | | search on the substance until— 22 |
|---|
| 377 | 377 | | ‘‘(A) the person withdraws the application 23 |
|---|
| 378 | 378 | | described in paragraph (1) of this subsection; 24 |
|---|
| 379 | 379 | | or 25 |
|---|
| 380 | 380 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00013 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 381 | 381 | | pbinns on DSKJLVW7X2PROD with $$_JOB 14 |
|---|
| 382 | 382 | | •HR 171 IH |
|---|
| 383 | 383 | | ‘‘(B) the Attorney General serves on the 1 |
|---|
| 384 | 384 | | person an order to show cause proposing the 2 |
|---|
| 385 | 385 | | denial of the application under section 304(c); 3 |
|---|
| 386 | 386 | | ‘‘(3) if the Attorney General serves an order to 4 |
|---|
| 387 | 387 | | show cause as described in paragraph (2)(B) and 5 |
|---|
| 388 | 388 | | the person requests a hearing, the hearing shall be 6 |
|---|
| 389 | 389 | | held on an expedited basis and not later than 45 7 |
|---|
| 390 | 390 | | days after the request is made, except that the hear-8 |
|---|
| 391 | 391 | | ing may be held at a later time if so requested by 9 |
|---|
| 392 | 392 | | the person; and 10 |
|---|
| 393 | 393 | | ‘‘(4) if the person sends a copy of the applica-11 |
|---|
| 394 | 394 | | tion described in paragraph (1) to a manufacturer or 12 |
|---|
| 395 | 395 | | distributor of the substance, receipt of the copy by 13 |
|---|
| 396 | 396 | | the manufacturer or distributor shall constitute suf-14 |
|---|
| 397 | 397 | | ficient evidence that the person is authorized to re-15 |
|---|
| 398 | 398 | | ceive the substance.’’. 16 |
|---|
| 399 | 399 | | (f) T |
|---|
| 400 | 400 | | REATMENT OF CERTAINMANUFACTURING AC-17 |
|---|
| 401 | 401 | | TIVITIES ASCOINCIDENT TORESEARCH.—Section 302 of 18 |
|---|
| 402 | 402 | | the Controlled Substances Act (21 U.S.C. 822), as amend-19 |
|---|
| 403 | 403 | | ed by subsection (e), is amended by adding at the end 20 |
|---|
| 404 | 404 | | the following: 21 |
|---|
| 405 | 405 | | ‘‘(i) T |
|---|
| 406 | 406 | | REATMENT OFCERTAINMANUFACTURINGAC-22 |
|---|
| 407 | 407 | | TIVITIES ASCOINCIDENT TORESEARCH.— 23 |
|---|
| 408 | 408 | | ‘‘(1) I |
|---|
| 409 | 409 | | N GENERAL.—Except as provided in para-24 |
|---|
| 410 | 410 | | graph (3), a person who is registered to perform re-25 |
|---|
| 411 | 411 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 412 | 412 | | pbinns on DSKJLVW7X2PROD with $$_JOB 15 |
|---|
| 413 | 413 | | •HR 171 IH |
|---|
| 414 | 414 | | search on a controlled substance may perform manu-1 |
|---|
| 415 | 415 | | facturing activities with small quantities of that sub-2 |
|---|
| 416 | 416 | | stance, including activities described in paragraph 3 |
|---|
| 417 | 417 | | (2), without being required to obtain a manufac-4 |
|---|
| 418 | 418 | | turing registration, if— 5 |
|---|
| 419 | 419 | | ‘‘(A) the activities are performed for the 6 |
|---|
| 420 | 420 | | purpose of the research; and 7 |
|---|
| 421 | 421 | | ‘‘(B) the activities and the quantities of 8 |
|---|
| 422 | 422 | | the substance involved in the activities are stat-9 |
|---|
| 423 | 423 | | ed in— 10 |
|---|
| 424 | 424 | | ‘‘(i) a notification submitted to the 11 |
|---|
| 425 | 425 | | Attorney General under section 303(l); 12 |
|---|
| 426 | 426 | | ‘‘(ii) a research protocol filed with an 13 |
|---|
| 427 | 427 | | application for registration approval under 14 |
|---|
| 428 | 428 | | section 303(f); or 15 |
|---|
| 429 | 429 | | ‘‘(iii) a notification to the Attorney 16 |
|---|
| 430 | 430 | | General that includes— 17 |
|---|
| 431 | 431 | | ‘‘(I) the name of the registrant; 18 |
|---|
| 432 | 432 | | and 19 |
|---|
| 433 | 433 | | ‘‘(II) an attestation that the re-20 |
|---|
| 434 | 434 | | search to be conducted with the small 21 |
|---|
| 435 | 435 | | quantities of manufactured substance 22 |
|---|
| 436 | 436 | | is consistent with the scope of the re-23 |
|---|
| 437 | 437 | | search that is the basis for the reg-24 |
|---|
| 438 | 438 | | istration. 25 |
|---|
| 439 | 439 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00015 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 440 | 440 | | pbinns on DSKJLVW7X2PROD with $$_JOB 16 |
|---|
| 441 | 441 | | •HR 171 IH |
|---|
| 442 | 442 | | ‘‘(2) ACTIVITIES INCLUDED.—Activities per-1 |
|---|
| 443 | 443 | | mitted under paragraph (1) include— 2 |
|---|
| 444 | 444 | | ‘‘(A) processing the substance to create ex-3 |
|---|
| 445 | 445 | | tracts, tinctures, oils, solutions, derivatives, or 4 |
|---|
| 446 | 446 | | other forms of the substance consistent with— 5 |
|---|
| 447 | 447 | | ‘‘(i) the information provided as part 6 |
|---|
| 448 | 448 | | of a notification submitted to the Attorney 7 |
|---|
| 449 | 449 | | General under section 303(l); or 8 |
|---|
| 450 | 450 | | ‘‘(ii) a research protocol filed with an 9 |
|---|
| 451 | 451 | | application for registration approval under 10 |
|---|
| 452 | 452 | | section 303(f); and 11 |
|---|
| 453 | 453 | | ‘‘(B) dosage form development studies per-12 |
|---|
| 454 | 454 | | formed for the purpose of requesting an inves-13 |
|---|
| 455 | 455 | | tigational new drug exemption under section 14 |
|---|
| 456 | 456 | | 505(i) of the Federal Food, Drug, and Cos-15 |
|---|
| 457 | 457 | | metic Act (21 U.S.C. 355(i)). 16 |
|---|
| 458 | 458 | | ‘‘(3) E |
|---|
| 459 | 459 | | XCEPTION REGARDING MARIHUANA .— 17 |
|---|
| 460 | 460 | | The authority under paragraph (1) to manufacture 18 |
|---|
| 461 | 461 | | substances does not include the authority to grow 19 |
|---|
| 462 | 462 | | marihuana.’’. 20 |
|---|
| 463 | 463 | | (g) T |
|---|
| 464 | 464 | | RANSPARENCY REGARDINGSPECIALPROCE-21 |
|---|
| 465 | 465 | | DURES.—Section 303 of the Controlled Substances Act 22 |
|---|
| 466 | 466 | | (21 U.S.C. 823), as amended by subsection (a), is amend-23 |
|---|
| 467 | 467 | | ed by adding at the end the following: 24 |
|---|
| 468 | 468 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00016 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 469 | 469 | | pbinns on DSKJLVW7X2PROD with $$_JOB 17 |
|---|
| 470 | 470 | | •HR 171 IH |
|---|
| 471 | 471 | | ‘‘(n) TRANSPARENCY REGARDINGSPECIALPROCE-1 |
|---|
| 472 | 472 | | DURES.— 2 |
|---|
| 473 | 473 | | ‘‘(1) I |
|---|
| 474 | 474 | | N GENERAL.—If the Attorney General de-3 |
|---|
| 475 | 475 | | termines, with respect to a controlled substance, that 4 |
|---|
| 476 | 476 | | an application by a practitioner to conduct research 5 |
|---|
| 477 | 477 | | with the substance should be considered under a 6 |
|---|
| 478 | 478 | | process, or subject to criteria, different from the 7 |
|---|
| 479 | 479 | | process or criteria applicable to applications to con-8 |
|---|
| 480 | 480 | | duct research with other controlled substances in the 9 |
|---|
| 481 | 481 | | same schedule, the Attorney General shall make 10 |
|---|
| 482 | 482 | | public, including by posting on the website of the 11 |
|---|
| 483 | 483 | | Drug Enforcement Administration— 12 |
|---|
| 484 | 484 | | ‘‘(A) the identities of all substances for 13 |
|---|
| 485 | 485 | | which such determinations have been made; 14 |
|---|
| 486 | 486 | | ‘‘(B) the process and criteria that shall be 15 |
|---|
| 487 | 487 | | applied to applications to conduct research with 16 |
|---|
| 488 | 488 | | those substances; and 17 |
|---|
| 489 | 489 | | ‘‘(C) how the process and criteria described 18 |
|---|
| 490 | 490 | | in subparagraph (B) differ from the process 19 |
|---|
| 491 | 491 | | and criteria applicable to applications to con-20 |
|---|
| 492 | 492 | | duct research with other controlled substances 21 |
|---|
| 493 | 493 | | in the same schedule. 22 |
|---|
| 494 | 494 | | ‘‘(2) T |
|---|
| 495 | 495 | | IMING OF POSTING.—The Attorney Gen-23 |
|---|
| 496 | 496 | | eral shall make information described in paragraph 24 |
|---|
| 497 | 497 | | (1) public upon making a determination described in 25 |
|---|
| 498 | 498 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00017 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 499 | 499 | | pbinns on DSKJLVW7X2PROD with $$_JOB 18 |
|---|
| 500 | 500 | | •HR 171 IH |
|---|
| 501 | 501 | | that paragraph, regardless of whether a practitioner 1 |
|---|
| 502 | 502 | | has submitted such an application at that time.’’. 2 |
|---|
| 503 | 503 | | SEC. 4. RULEMAKING. 3 |
|---|
| 504 | 504 | | (a) I |
|---|
| 505 | 505 | | NTERIMFINALRULES.—The Attorney Gen-4 |
|---|
| 506 | 506 | | eral— 5 |
|---|
| 507 | 507 | | (1) shall, not later than 1 year of the date of 6 |
|---|
| 508 | 508 | | enactment of this Act, issue rules to implement this 7 |
|---|
| 509 | 509 | | Act and the amendments made by this Act; and 8 |
|---|
| 510 | 510 | | (2) may issue the rules under paragraph (1) as 9 |
|---|
| 511 | 511 | | interim final rules. 10 |
|---|
| 512 | 512 | | (b) P |
|---|
| 513 | 513 | | ROCEDURE FORFINALRULE.— 11 |
|---|
| 514 | 514 | | (1) E |
|---|
| 515 | 515 | | FFECTIVENESS OF INTERIM FINAL 12 |
|---|
| 516 | 516 | | RULES.—A rule issued by the Attorney General as 13 |
|---|
| 517 | 517 | | an interim final rule under subsection (a) shall be-14 |
|---|
| 518 | 518 | | come immediately effective as an interim final rule 15 |
|---|
| 519 | 519 | | without requiring the Attorney General to dem-16 |
|---|
| 520 | 520 | | onstrate good cause therefor, notwithstanding sub-17 |
|---|
| 521 | 521 | | paragraph (B) of section 553(b) of title 5, United 18 |
|---|
| 522 | 522 | | States Code. 19 |
|---|
| 523 | 523 | | (2) O |
|---|
| 524 | 524 | | PPORTUNITY FOR COMMENT AND HEAR -20 |
|---|
| 525 | 525 | | ING.—An interim final rule issued under subsection 21 |
|---|
| 526 | 526 | | (a) shall give interested persons the opportunity to 22 |
|---|
| 527 | 527 | | comment and to request a hearing. 23 |
|---|
| 528 | 528 | | (3) F |
|---|
| 529 | 529 | | INAL RULE.—After the conclusion of such 24 |
|---|
| 530 | 530 | | proceedings, the Attorney General shall issue a final 25 |
|---|
| 531 | 531 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00018 Fmt 6652 Sfmt 6201 E:\BILLS\H171.IH H171 |
|---|
| 532 | 532 | | pbinns on DSKJLVW7X2PROD with $$_JOB 19 |
|---|
| 533 | 533 | | •HR 171 IH |
|---|
| 534 | 534 | | rule to implement this Act and the amendments 1 |
|---|
| 535 | 535 | | made by this Act in accordance with section 553 of 2 |
|---|
| 536 | 536 | | title 5, United States Code. 3 |
|---|
| 537 | 537 | | Æ |
|---|
| 538 | 538 | | VerDate Sep 11 2014 23:19 Jan 18, 2023 Jkt 039200 PO 00000 Frm 00019 Fmt 6652 Sfmt 6301 E:\BILLS\H171.IH H171 |
|---|
| 539 | 539 | | pbinns on DSKJLVW7X2PROD with $$_JOB |
|---|